Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Post by TechGuy01on Jul 06, 2024 9:14am
227 Views
Post# 36120959

3 years starting Nov 2023...

3 years starting Nov 2023...Excerpt from the agreement Markowski struck with the prior BOD last fall. Could be up to 3 years for this to play out. Staying patient and full of hope for this wonderful life saving technology!

The Voting Trust Agreement has a term of three years, subject to early termination in the event that the Company does not hold any technology, intellectual property or other commercial licences (collectively, the “Technology IP”) from the University Health Network or transferred to it by Pivot Financial I Limited Partnership (“Pivot”). At the time of Mr. Matthews’ resignation, the Company did not hold any license to the Technology IP however Mr. Matthews has been informed that the Company’s new board of directors intends to seek such licenses in connection with a proposed restructuring (the “Restructuring”) of the Company to be overseen by the new board. 
<< Previous
Bullboard Posts
Next >>